Julie Papanek Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 48,894 shares at $21.21 ($1.0M) on 2023-02-01, disclosed to the SEC on 2023-02-03.
Open-market sale of $1.0M DAWN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.21 | 23,894 | $507K | 48.8% |
| 2 | $21.21 | 23,894 | $507K | 48.8% |
| 3 | $21.69 | 1,106 | $24K | 2.3% |
| Total | $21.22 avg | 48,894 | $1.0M | 100% |
| Filing → |
| DAWN | SELL | 2022-12-12 | $192K | — | Filing → |
| DAWN | SELL | 2022-12-05 | $320K | — | Filing → |
| DAWN | SELL | 2022-11-03 | $300K | — | Filing → |